These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6099346)

  • 1. Neuroendocrinological study of opioid and serotoninergic systems in migraine patients.
    Bussone G; Boiardi A; La Mantia L; Frediani F; Martini A; Di Giulio AM; Panerai AE
    Ital J Neurol Sci; 1984 Dec; 5(4):413-6. PubMed ID: 6099346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for serotoninergic system involvement in opioid control of luteinizing hormone secretion in man.
    Foresta C; Mioni R; Scandellari C
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):573-8. PubMed ID: 3621624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting ergot: clinical and neuroendocrinological aspects in migraine patients.
    Bussone G; Boiardi A; La Mantia L; Frediani F; Vescovi A; Parati EA
    Cephalalgia; 1983 Aug; 3 Suppl 1():163-7. PubMed ID: 6311423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
    Bero LA; Lurie SN; Kuhn CM
    Brain Res; 1987 Dec; 465(1-2):189-96. PubMed ID: 2894234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of prolactin secretion by morphine: role of the central serotonergic system.
    Koenig JI; Mayfield MA; McCann SM; Krulich L
    Life Sci; 1979 Sep; 25(10):853-63. PubMed ID: 158692
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI; Mayfield MA; McCann SM; Krulich L
    Life Sci; 1984 May; 34(19):1829-37. PubMed ID: 6330479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone reduces the fenfluramine-induced prolactin release in man.
    Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic naloxone administration, a potential treatment for migraine, enhances morphine-induced miosis.
    Nicolodi M; Sicuteri F
    Headache; 1992 Jul; 32(7):348-52. PubMed ID: 1526766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
    Gold MS; Redmond DE; Donabedian RK
    Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms.
    Spiegel K; Kourides IA; Pasternak GW
    Science; 1982 Aug; 217(4561):745-7. PubMed ID: 6285470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of morphine and naloxone on histamine- and serotonin-induced bronchospasms].
    Karpov OI
    Farmakol Toksikol; 1990; 53(1):36-8. PubMed ID: 2158463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal steroid modulation of brain opioid systems.
    Limonta P; Maggi R; Dondi D; Martini L; Piva F
    J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
    Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L
    Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl stimulates prolactin release through mu-opiate receptors, but not the serotonergic system.
    Pan JT; Teo KL
    Endocrinology; 1989 Oct; 125(4):1863-9. PubMed ID: 2551630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-steroid interactions in the modulation of the hypothalamic-pituitary axis.
    Martini L; Dondi D; Limonta P; Maggi R; Motta M; Piva F
    Adv Exp Med Biol; 1987; 219():3-20. PubMed ID: 2829577
    [No Abstract]   [Full Text] [Related]  

  • 18. Naloxone does not modify fenfluramine-induced prolactin increase in obese patients.
    Argenio GF; Bernini GP; Vivaldi MS; del Corso C; Santoni R; Franchi F
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):505-8. PubMed ID: 1769132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of neuroendocrine axes in patients with menstrual migraine.
    Fioroni L; Martignoni E; Facchinetti F
    Cephalalgia; 1995; 15(4):297-300. PubMed ID: 7585927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.